Jim Broderick, M.D.
Jim Broderick is an accomplished biotech executive with more than 20 years of experience in the industry. He was Co-Founder and Chairman of Ra Pharmaceuticals (acquired by UCB, Brussels), founding CEO of SetPoint Medical, and Co-Founder and Chairman of Promedior, while he was a partner at the venture capital firm Morgenthaler Ventures. Jim founded Palleon in collaboration with the venture capital firm SR One, where he served as an Entrepreneur-in-Residence. He earned a Bachelor of Science degree in mechanical engineering from MIT and an MD from UMass Medical School.